2565. In vitro synergistic bacterial killing of imipenem and ceftaroline against Mycobacterium abscessus; a static concentration time-kill analysis

BACKGROUND: Mycobacterium abscessus (Mab) represents a significant clinical challenge, with a rising incidence in recent times. The current therapeutic approach, which involves prolonged IV administration of amikacin, is associated with notable toxicities. Consequently, there is a pressing need to e...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Eunjeong, Nantongo, Mary, Holland, Steven M, Kreiswirth, Barry N, Dousa, Khalid M, bonomo, Robert A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677834/
http://dx.doi.org/10.1093/ofid/ofad500.2182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677834/
http://dx.doi.org/10.1093/ofid/ofad500.2182

Ejemplares similares